当商品の販売は、2011年07月19日を持ちまして終了しました。
Abstract
Standardization of Products Necessary to Drive Acceptance of Microarrays
as Diagnostic Tools
Manufacturers of DNA microarrays are seriously challenged to overcome
laboratory-to-laboratory and platform-to-platform inconsistencies. Result
variability can be linked to a variety of reasons including varying probe length
and labeling protocols. Manufacturers are spending considerable time and effort
in comparing their products with 'industry standards' that include quantitative
polymerase chain reaction and other microarray platforms. Standardization of
data is expected to be an essential part of microarrays becoming effective
diagnostic tools.
This Frost & Sullivan research service examines the World DNA Microarray
Markets and discusses the competitive factors in them. It segments the market
into commercial, self-printed, and software products, and breaks down total
revenues by the three major geographic locations - United States, Europe, and
Rest-of-World. Industry challenges, strategies, market trends and opportunities
are described in detail, and have been derived through extensive interviews with
market participants.
Gene Expression Analyses Being Increasingly Used for Clinical Trials
Gene expression products are quickly becoming integral tools for both
pre-clinical and clinical research. "Gene expression analysis provides a
snapshot of what is happening in a system at the molecular level," states
the analyst. This information is vital to understand the workings of the system
and the factors that change the system.
The utility of microarray technology in the diagnostics arena is beginning to
be explored. In diagnostics, microarray technology is expected to be crucial for
making decisions relating to therapeutics. Microarrays have been used in
research for almost a decade; however, it is their promise as a therapeutic tool
that is expected to drive the market.
Commercial Products to Drive Market Growth
World DNA microarray revenue was $596 million in 2003 and is expected to
reach $937 million by 2010, at a compound annual growth rate of 6.7 percent.
Market growth is expected to be derived from the substantial gains in the
commercial market and continued growth in the scanner market.
Table of Contents
- STRATEGIC ANALYSIS OF WORLD DNA MICROARRAY MARKETS
- Introduction
- Introduction
- Disclaimer
- Certification
- Research Scope and Methodology
- Overview and Scope
- Outline Slide
- Summary of Findings
- Market Maturation Process
- Customer Priorities
- Competitive Framework
- Potential Threats
- Market Potential
- Strategic Analysis
- Outline Slide
- Market Segmentation
- Market Drivers
- Market Restraints
- Industry Challenges
- Challenges & Strategies I
- Challenges & Strategies II
- Challenges & Strategies III
- Challenges & Strategies IV
- Market Trends
- Technology Trends
- Total Market
- Outline Slide
- Key Market Engineering Measurements
- Executive Quote I
- Total Market Revenue Forecast
- Revenue Analysis
- Total Market Revenue Forecast by Segment
- Geographical Breakdown
- Understanding Growth Opportunities
- Market Positioning
- Commercial Segment
- Outline Slide
- Key Market Engineering Measurements
- Executive Quote II
- Commercial Market Revenue Forecast
- Revenue Analysis
- Commercial Market Revenue Forecast by Segment
- Revenue Forecast - Commercial Instruments
- Revenue Forecast - Commercial Reagents
- Revenue Forecast - Commercial Pre-printed Microarrays
- Forecast Assumptions
- Market Share - Commercial Microarray Products
- Understanding Growth Opportunities
- Revenue Forecast - Molecular Diagnostics Scenario
- Self-printed Segment
- Outline Slide
- Key Market Engineering Measurements
- Self-Printed Market Revenue Forecast
- Revenue Analysis
- Self-Printed Market Revenue Forecast by Segment
- Revenue Forecast - Scanners
- Revenue Forecast - Arrayers
- Revenue Forecast - Hybridization Instruments
- Revenue Forecast - Array Content
- Forecast Assumptions
- Understanding Growth Opportunities
- Software Segment
- Outline Slide
- Key Market Engineering Measurements
- Executive Quote III
- Software Market Revenue Forecast
- Forecast Assumptions
- Revenue Analysis
- Understanding Growth Opportunities
- Software Vendor Competitive Positioning
- Competitive Landscape
- Outline Slide
- Company Analysis I
- Company Analysis II
- Company Analysis III
- Company Analysis IV
- Company Analysis V
- Company Analysis VI
- Company Analysis VII
- Company Analysis VIII
- Company Analysis IX
- Company Analysis X
- Company Analysis XI
- End-User Survey
- Outline Slide
- Respondent Profile I
- Respondent Profile II
- Microarray Access
- Analysis of Model System
- Type of Array Used
- Self-Printed Arrays I
- Self-Printed Arrays II
- Self-Printed Arrays III
- Self-Printed Arrays IV
- Self-Printed Arrays V
- Commercial Arrays I
- Commercial Arrays II
- Commercial Arrays III
- Commercial Arrays IV
- Consumables I
- Consumables II
- Micorarray Analysis Software I
- Micoarray Analysis Software II
- Microarray Purchasing Decisions
- Decision Support Database
- Outline Slide
- Biochemists and Biophysicists
- Biological and Medical Scientists
- Biotechnology Companies I
- Biotechnology Companies II
- Sequencing Centers
- Frost & Sullivan Awards
- Outline Slide
- Introduction to Frost & Sullivan Awards
- Technology Leadership Award
- Product Innovation Award
- Product Line Quality
- Frost & Sullivan
- Outline Slide
- Healthcare Team
- Our Capabilities
- Key Advantages
- Our Consulting Clients
- Frost & Sullivan Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Services
- Growth Partnership Service Platform
